chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt reported hives 3 hours after vaccine was given. States also had same hives when she had COVID prior to vaccination. Reports not having hives on the first dose. Advised patient to go to urgent care for work up to which she agreed.
17-year old daughter who received the first dose of Moderna covid-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17-year old daughter who received the first dose of Moderna covid-19 vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17-year old daughter who received the first dose of Moderna covid-19 vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17-year old daughter who received the first dose of Moderna covid-19 vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medication information was reported. The report is from a mother regarding a 17-year old daughter who received the first dose of Moderna covid-19 vaccine three weeks ago. Her daughter went to school and enrolled for receiving the vaccine not knowing about the recommended age. The vaccine provider gave her the first shot after checking the age in the driver's license ID. As per the card she went on to receive the second shot and they denied her for the second shot based on her age. The reporter did not have the product information and hurried disconnected the call said would be calling back in some time. The reporter had question if her daughter can take the vaccine at the age 17 and if yes, reporter needed help in getting one as now her daughter is denied for her age. The case number was given to the patient. The reporter gave the facility address where the patient received the shot.
Tested positive for Covid19 PCR test on 14Apr2021, after receiving the first dose of the Covid19 vaccine on 2Apr2021; symptoms started on 8Apr2021 with a negative Covid19 rapid test that day.; This is a spontaneous report from a contactable consumer (patient).   A 47-year-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in arm left on 02Apr2021 19:00 (Batch/Lot Number: ER8732) as single dose at the age of 47-year-old for COVID-19 immunisation.  The patient medical history and concomitant medications were none.  No history of all previous immunization with the Pfizer vaccine considered as suspect. No additional vaccines administered on same date of BNT162B2. No prior vaccinations (within 4 weeks). No events following prior vaccinations. The patient he got COVID in between the two doses: COVID-19 symptoms started on 08Apr2021 with a negative COVID-19 rapid test on 08Apr2021 and was tested positive for COVID19 PCR test on 14apr2021, after receiving the first dose of the COVID-19 vaccine. The events did not require a visit to Emergency Room? Or Physician Office. He received treatment with Tylenol. On 20Apr2021 he stopped the medication and he was feeling better now. The events were considered medically significant. The patient underwent lab tests and procedures which included Sars-cov-2 test: positive on 14Apr2021, Sars-cov-2 test negative: negative on 08Apr2021. The outcome of event was unknown. This report was note related to a study or program. His second dose was scheduled for 23Apr2021. Caller was asking if he was still safe to get the vaccine or should he wait. A Product Complaint was filed.
About 1 hour after receiving vaccine, patient broke out in hives on chest, arms, and face. Also had an itchy throat, but no trouble breathing. About 1 hour later & after taking Benadryl, patient said the hives had stopped, tongue had swollen some but swelling was now going down, but she had no sense of taste or smell. Spoke to patient again about 5 hours later, she said the tongue swelling had stopped, hives had stopped, but she still had no taste or smell. I advised her to follow up with her regular doctor the next day.
4/25 - Woke up in excruciating pain to the point if I wasn't in the fetal position it hurt horrible. The reaction was inflammation to all my joints - fingers, nuckles, wrist, elbow, shoulders, neck, jaw, lower back, knees, and ankles. My body was so stiff from pain that walking was painful, and movement was tough. My skin was very sensitive too, like flu-like symptoms without the fever. Non-stop sweating then freezing - it was too hot to be under a blanket but too cold not to be. No treatment except for Panaway oil. I ended up sleeping most of the day on and off when the pain would reduce slightly. I was slightly nauseous but lethargic.   4/25 - still in pain, but can move better. I saw my chiropractor for an adjustment and she could tell I was in a lot of pain. I was sensitive to the tough, and she recommended hydrating way more. The joint pain had lessened only slightly but enough where I get up and move around for a short period of time. The most pain right now is the arm muscles which is expected. More nausea and headachy today.
#23 Pneumonia Vacinne-second in the Series-#13 given 5/8/19. 15 minutes after injection I left and went to the parking lot, I immediately felt a tingling and aching in the back of both thighs. I sat down in the car and the sensation was also by then in the middle core of my body bellybutton height. The pain was excrushiating  . and I decided I need to go back in. By then the same symptoms went up and down my left arm to the shoulder then did the same on the right arm. By the time I got into the Dr's office I was bent over and needed to pull myself up the stairs to assist going up the flight of stairs.I got the staff attention very quickly. They responded and took vital-No BP problems;no Rash;no temperature;no piulse problems. Everything was Ok. . Symptoms resided in 30-60 mins. Dr. kept me about 90 mins to make sure I was Ok before I Left. Dr. talked to Pfizer but They didn't contact me. Now I have been advised to not take the COVID -19 Vacinne or any other one?
At 11:29 a female patient  asked for my assistance.Patient complained of dizziness when putting her head back. Also stated she had some numbness and tingling in her arms and hands. Patient was  pale. Patient was unsure if her symptoms were related to the vaccine or if they could be related to her MS. The patient was walked with me to a private area where we sat her down and took her BP (106/54), pulse (88) and Oxygen sat  (100). We monitored said patient for 30 minutes. We provided her with warm blankets, water and asked her to eat a snack that she had with her. Vitals were monitored numerous times over the course of the 30 minutes with all vitals remaining in the same general range. Her temperature was 98.4. Over the course of the 30 minutes patient's cheeks became rosy and improved in color. Patient began to move about more, scanning her phone and engaging more freely in conversation. At the end of 30 minutes we took her BP sitting and standing and there was no significant difference. At this point the patient felt comfortable leaving our area. We offered continued assistance if she felt she needed it. Patient declined. Patient was encouraged to go home and rest and have someone available to monitor her for the rest of the day. Patient stated her son lived down the street and she would have him come over to her house. Patient stated she felt like she does after a long stressful day at work. Patient stated that her MS often causes her to feel like this when she exercises or works a long day at work. Patient discharged home ambulatory to her home and care of her son.
Narrative: COVID infection following COVID vaccine series 02/26, Pfizer, dose #1 03/18, Pfizer, dose #2 10/12, Pfizer, dose #3 08/29 pt cc: chills, cough, fatigue, fever, headache, loss of taste or smell, myalgias, exposure: unknown 08/30 SARS-COV-2 Variant Sequencing result: pending 08/30 COVID swab, result: detected
Swollen lymph nodes x 5 days, day of injection increased heart rate (not less than 100 bpm) continued ear pain, hot red to the touch and intermittently running 102 outside the ear, blurry vision
pt recvd vax;20 min p/ vax, infant stiffened, arched,eyes rolled back then became limp;was afebrile;observed in hosp over noc;2 days later similar event occured at home;work up neg; infant appeared nl; no fever;
Pt recvd vax & approx 1 month & later found out was pregnant; 17MAY90 delivered via Cesarean section; following the delivery devel uterine infection that required ATB & hsopitalization;
Fluzone High-dose was given at 0905 and pt did start to have an allergic reaction to the vaccine at 0910. Pts voice became very hoarse sounding and pt stated that "I feel like my throat is closing." Pt was given Dexamethasone 4mg IM at 0915 along with Benadryl 50mg IM at 0930. Pt states she felt better. Pts voice to become clear sounding. At about 0950 pt started to sound hoarse again and stated that she felt like her throat was closing again. Pt was given Dexamethasone 4mg IM again at 1005 along with calling 911. Vital signs were taken continuously throughout episode and stable. SpO2 was never <96%. Ambulance came and took pt to ED. Husband was at wife's side throughout and met the ambulance at the hospital. Pt stable when leaving office. Pt was A/O x 4, pt walked from room to stretcher, VVS. Pt denied sob and cp.
Injection site with warmth, swelling, erythema and induration (L) deltoid.
Bronchitis; Pharyngitis; Coughed up blood; Hoarse voice; Treatment non compliance; Inappropriate route of vaccination; This spontaneous case was reported by a health care professional and describes the occurrence of BRONCHITIS (Bronchitis), PHARYNGITIS (Pharyngitis), HAEMOPTYSIS (Coughed up blood) and DYSPHONIA (Hoarse voice) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product MACITENTAN for Primary pulmonary hypertension.    Concurrent medical conditions included Primary pulmonary hypertension. Concomitant products included TADALAFIL (ADCIRCA) and RIVAROXABAN (XARELTO) for an unknown indication.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) 1 dosage form and MACITENTAN (Oral) 10 mg. On an unknown date, the patient experienced BRONCHITIS (Bronchitis) (seriousness criterion hospitalization), PHARYNGITIS (Pharyngitis) (seriousness criterion hospitalization), HAEMOPTYSIS (Coughed up blood) (seriousness criterion hospitalization), DYSPHONIA (Hoarse voice) (seriousness criterion hospitalization), TREATMENT NONCOMPLIANCE (Treatment non compliance) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Inappropriate route of vaccination). The patient was hospitalized from 28-May-2021 to 01-Jun-2021 due to BRONCHITIS, DYSPHONIA, HAEMOPTYSIS and PHARYNGITIS. At the time of the report, BRONCHITIS (Bronchitis), PHARYNGITIS (Pharyngitis), HAEMOPTYSIS (Coughed up blood), DYSPHONIA (Hoarse voice), TREATMENT NONCOMPLIANCE (Treatment non compliance) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Inappropriate route of vaccination) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-May-2021, Blood pressure measurement: low (Low) Low. On 28-May-2021, Oxygen saturation: low (Low) Low.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous), the reporter did not provide any causality assessments.   Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not applicable.  Company Comment: Very limited information regarding these  events have  been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding these  events have  been provided at this time.  Further information has been requested.
No adverse event. Pt was mistakenly given flu vaccine instead of TB skin test serum.
Higher than normal PSA levels (2x). Biopsy confirmed enlarged prostate. Difficulty in urinating.
Week of NOv. 24th did not have energy, tired. Week of Dec. 8th. had weird feelings in hands and toes.(felt like I had needles in my hands and feet.) Dec. 21st. went to emergency room at medical center. Saw Dr. and he gave me  Vicodin. He felt I had pulled my back.Took meds for three days. Did not like how I felt that is why I went off the meds. Dec. 26th. returned to medical center and Dr. said I had BEll's Palsy. Finally because of my son who demanded I go to another Hospital. Because I could not stand ,walk,talk and had the needle feeling in both my hands and feet my son wanted me to go to the Hospital.I was admitted to Hospital. A Neurologist, did a  spinal tap and said I had Gullian-Barre syndrome and placed me in ICU.Where my treatment took place. I received five plasma exchanges. After the hospital I was in rehab for two weeks and physical therapy still on going.  9/8/09 Hospital records received DOS 12/26/08 to 1/03/09. Assessment Gullain-Barre syndrome, possibly due to flu vaccine. Patient presented initially due to back pain followed by numbness in her face and right facial weakness. Nausea and vomiting after eating pork chop. Mild generalized weakness. Tingling in hands and feet. Plasma exchange. Also constipation, rectal bleeding. Thoracic disc protrusion, discogenic disease. Cervical spine degenerative changes. Treated with Plasmapheresis. Paresthesias hands and feet. Wide base of gait.  ICD-9 Codes: 357.0 Guillain-Barre Syndrome, 569.3 Anorectal bleeding, 564.00 Unspecified constripation, 405.99 Unspecified secondary hypertension other cause, 458.9 Hypertension unspecified, E849.7 Injury or poisoning occuring in residential institution, 781.94 Facial weakness, E949.6 Adverse effects of other and unspecified viral and rickettsial vaccines, E849.9 Injury or poisoning occuring in an uspecified place, E879.8 Later complication of an unspecified procedure.
Tinnitus, ringing in the ears. Both left and right more in my right. It started off intermittent and is now louder & 24/7. It interferes with sleep
Information has been received from a physician concerning a female who on approximately 03-JUN-2008 was vaccinated with ZOSTAVAX. On approximately 17-JUN-2008 the patient experienced acute polyarthritis which has affected her arms, shoulders and knees. The patient's acute polyarthritis persisted. The patient sought medical attention and saw physician. Additional information has been requested.
This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 78-year-old male patient who received SHINGRIX for prophylaxis. On 4th May 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follows: The lot number and expiration date was not available. No additional information was available because healthcare professional had to go. The healthcare professional on call was not the healthcare professional who administered vaccine. This case has been linked with the case US2018128790, reported by the same reporter.
7 days after receiving MMRV, DTaP, HIB, PCV-7, and flu, had fever to 102.9. Soon after had seizure lasting approx. 4 minutes. Presumed related to MMR.
The injection site was red swollen,itchy, appeared 4x4inch area of the arm and warm to touch for about 1 wk  to 2 wks.
Macularpapular rash on bilateral hands and feet with some clear filled vesicles.  Rash can be found on both palmar/plantar surfaces as well as volar surfaces.  Patient responded to oral diphenhydramine 25mg PO q6h.  Pt was also given prednisone 40mg PO for 5 days.
only our shoulders was hurting a little but we had not fever; This is a spontaneous report from a contactable consumer. This consumer reported for 5 patients. This is 2nd of 5 reports.   A patient of unspecified age and gender received BNT162B2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection, Batch/Lot number and expiration dates were not reported), via an unspecified route of administration on an unspecified date as unknown dose number, single for COVID-19 immunisation. The patient medical history and concomitant medications was not reported. It was reported that, there was 5 of us and none of us had reactions, only our shoulders were hurting a little, but we had not fever" with outcome of unknown.   Information on the lot/ batch number has been requested.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021171049 same drug/AE, different patient.
Fever,chills, lack of taste, diarrhea, same symptoms as when I had covid19 last year in May.
who are fully vaccinated who tested positive; who are fully vaccinated who tested positive; This is a spontaneous report from a contactable consumer or other non hcp.     A patient of unspecified age and gender received first dose of first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EW0167), via an unspecified route of administration, administered in Arm Right on 27Apr2021 as single dose and patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EW0178) via an unspecified route of administration, administered in Arm Right on 18May2021 ,as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient taking COVID Vaccine for COVID prevention. Prior Vaccinations within four weeks prior to the first administration date of the suspect vaccine was none. It was reported that relevant test was none.It was reported that  Investigation Assessment was No. Adverse event following prior vaccinations was None. It was reported that Additional Vaccines Administered on Same Date of the Pfizer Suspect was None. It was reported that History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations were not available) was None. Time the Vaccination Given was late morning. The patient experienced who are fully vaccinated who tested positive on 2021. It was reported that Emergency Room and Physician Office visit was no. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 2021. The outcome of the events was unknown.  Follow-Up (25Aug2021): Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101095688 same reporter/drug/AE, different patients.
got tested  positive for  covid-19; got tested positive for covid-19; Second dose after 38 days; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (got tested  positive for  covid-19), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose after 38 days) and DRUG INEFFECTIVE (got tested positive for covid-19) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose after 38 days). On 24-Aug-2021, the patient experienced COVID-19 (got tested  positive for  covid-19) and DRUG INEFFECTIVE (got tested positive for covid-19). On 22-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose after 38 days) had resolved. On 24-Aug-2021, DRUG INEFFECTIVE (got tested positive for covid-19) had resolved. At the time of the report, COVID-19 (got tested  positive for  covid-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Aug-2021, SARS-CoV-2 test positive: positive (Positive) Positive.         No Concomitant medications were provided.  No Treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 30-Aug-2021: Follow-up information included no new information.; Sender's Comments: Based on the mechanism of action of mRNA-1273 causal association between the event of COVID-19 infection and mRNA-1273 is assessed as not applicable. This is a case of lack of effect despite the patient had 2 doses of Moderna vaccine in an inappropriate interval (25-35 days).
It has been 25 years since received Flu vaccine due to problems experienced. Similar to previous reaction. 2 weeks later problems started. Welts all over body, lip/eye swelling. Growth on left eye Pterygium which was clear/pinkish turned milky white. Both eyes are foggy. Went to the doctor a week ago and recommended over the counter antihistamines which have helped. Current status, eye problems continue.
pt recvd vax & w/in a month p/vax exp tenderness of connective tissues, body aches, & diff walking for approx 6month;pt was found to have fibromyalgia;
Rashes are red; itchy; Rashes on right arm/ Rashes are comes and go; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Rashes are red), RASH PRURITIC (itchy) and RASH (Rashes on right arm/ Rashes are comes and go) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033B21A) for COVID-19 vaccination.     Concurrent medical conditions included Bladder disorder and Neuropathy. Concomitant products included Blood pressure medicine.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-May-2021, the patient experienced RASH ERYTHEMATOUS (Rashes are red), RASH PRURITIC (itchy) and RASH (Rashes on right arm/ Rashes are comes and go). At the time of the report, RASH ERYTHEMATOUS (Rashes are red), RASH PRURITIC (itchy) and RASH (Rashes on right arm/ Rashes are comes and go) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was reported that patient is taking blood pressure medicine as concomitant. No treatment medication was taken.